We’re proud to share the SRF’s 2025 Annual Report, Progress Made Bold, a reflection of nearly four decades of relentless research and the unstoppable scleroderma community that makes it possible.
Together, we invested $8.7 million in research in 2025 alone–more than any other year in our history–accelerating discoveries that are bringing us closer than ever to better treatments, and ultimately, a cure.
Today, we’re entering a new era of disease-modifying therapies. That’s not optimism. That’s science. We welcome you to read the report to learn more.
